Health and Biotechnology: generating new business opportunities in Brazil

Location: FIESP - Federation of Industries of the State of São Paulo, 4º and  11º Floor. Av. Paulista, 1311, São Paulo-SP, Brazil
Date: 5-6 October  2017
Sectors: Health and Biotechnology
Organiser: ANPROTEC in collaboration with CPqD, Agência USP de Inovação, CONFAP, BIOMINAS and TECNALIA, and in cooperation with FIESP, ELANBiz, Latin America SME IPR Helpdesk and ABIMO.
Price: Free (registration required)
Travel funds: limited travel funds available for European organisations. Deadline for applications: 20th of September. Contact: Mikel Emaldi,
Hashtag: #ELANnetworkBR



NOTE: In order to attend the event, it is necessary to register in the registration system (REGISTRATION button). If you want to hold bilateral meetings, you should also register with the B2B tool (MATCHMAKING button) and schedule the meetings you want .

The Health and Biotechnology sector (cosmetics, toiletries, pharmaceuticals, food, chemistry and health services, among others) has been identified as one of the strategic sectors for Brazil, in order to face in a better way, the challenges of Health and Biotechnology sector.


  • Identify the challenges in the Health and Biotechnology sector in Brazil  and generate spaces and mechanisms to help transform these challenges into sustainable collaboration between SMEs from Europe and Brazil to develop technology-based business opportunities.
  • Consolidate collaboration areas in the business opportunities based in technology and innovation.
  • Provide a space to find the right partners to overcome existing and future market challenges. 
  • Link agents supporting business opportunity generation, such as financial bodies, market and technology experts, initiatives for the promotion of business between Brazil and Europe, etc.
  • Generate bilateral meetings between potential European and Brazilian partners in order to promote the co-generation of specific opportunities.

Brazil is a hub  used by foreign health companies to penetrate the Latin American market. Brazil is the largest market in South America, accounting for 40% of demand. The country is also part of regional trade agreements allowing Brazilian based exporters to sell pharmaceuticals duty free or with highly preferential conditions within Latin America. Furthermore, regulations allow most pharmaceuticals and medical devices made in Brazil to be sold directly in most Brazilian export markets. Further opportunities exist in the area of e-health/m-health which is a high growth market in Brazil. The biotechnology sector has over 230 companies serving a $6-7 billion market (2016).

Brazil has consolidated its position as a strong and attractive global player with a high degree of economic diversification and is currently the seventh largest economy in the world. Economic development in recent years has resulted in an expanded mass consumer market and increased social equality, an environment of institutional stability and increased social cohesion. The increase in purchasing power and investment opportunities in sectors like health, biotechnology, oil and natural gas, electricity generation and transmission, real estate and agribusiness makes Brazil an attractive choice for investment. The country is currently the sixth biggest Foreign Direct Investment (FDI) recipient in the world (UNCTAD, 2016).

This event is the third that the ELAN Network has organised in Brazil. In 2016, more than 50 bilateral meetings were held and over 30 business opportunities were identified between European and Brazilian SMEs.




  • Companies interested in generating technology-based business opportunities (TBBOs) within the framework of the country challenges identified in the Health and Biotechnology sector.
  • Regional and local governments.
  • Technological centres, universities, research institutes and other knowledge-based organisations.
  • Clusters, business associations and other organisations supporting business.


  • Identification of challenges in Brazil in the Health and Biotechnology sector.
  • Elevator pitches of the capacities of participating companies.
  • Business co-creation sessions.
  • Thematic workshops.
  • Networking activities.
  • B2B meetings.



  • Cell therapy
  • Regenerative medicine and tissue engineering
  • Genetic and molecular testing
  • Biofuels
  • Foods
  • Reagents
  • Environment


  • Medical and dental devices
  • Clinical diagnostic
  • e-health and m-health
  • Pharmaceuticals
  • Hospital and laboratory equipment
  • Implants and  vaccines
  • Consumables